Funding for this research was provided by:
MEXT, Japan (20K08885, 20K21655)
Takeda Science Foundation
Okayama Medical Foundation
Astellas Pharma Inc. Research Support
Article History
Received: 5 May 2022
Accepted: 3 November 2022
First Online: 22 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.